Roth Capital Slashes PT on Dendreon (DNDN) to 15c; Sale Unlikely Following Ch. 11 Filing
Tweet Send to a Friend
Roth Capital affirms Dendreon (Nasdaq: DNDN) at Sell and cuts it price target from $0.50 down to $0.15. Earlier ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
